Cipla Receives Inspection Report From US Regulator For Indore Facility

New Delhi: Drug major Cipla on Wednesday said it has received an establishment inspection report (EIR) from the US health regulator for its Indore plant after completion of inspection there. The company has "received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Indore facility indicating formal closure of the USFDA inspection conducted in July/August, 2015", Cipla said in ...